Literature DB >> 10834890

Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study.

P James1, C J Ellis, R M Whitlock, A R McNeil, J Henley, N E Anderson.   

Abstract

OBJECTIVE: To assess whether a raised serum troponin T concentration would be an independent predictor of death in patients with an acute ischaemic stroke.
DESIGN: Observational study.
SETTING: Auckland Hospital, Auckland, New Zealand.
SUBJECTS: All 181 patients with an acute ischaemic stroke admitted over nine months in 1997-8, from a total of 8057 patients admitted to the acute medical service. MAIN OUTCOME MEASURES: Blood samples for measuring troponin T concentration were collected 12-72 hours after admission; other variables previously associated with severity of stroke were also recorded and assessed as independent predictors of inpatient mortality.
RESULTS: Troponin T concentration was raised (>0.1 microgram/l) in 17% (30) of patients admitted with an acute ischaemic stroke. Thirty one patients died in hospital (12/30 (40%) patients with a raised troponin T concentration v 19/151 (13%) patients with a normal concentration (relative risk 3.2 (95% confidence 1.7 to 5. 8; P=0.0025)). Of 17 possible predictors of death, assessed in a multivariate stepwise model, only a raised troponin T concentration (P=0.0002), age (P=0.0008), and an altered level of consciousness at presentation (P=0.0074) independently predicted an adverse outcome.
CONCLUSIONS: Serum troponin T concentration at hospital admission is a powerful predictor of mortality in patients admitted with an acute ischaemic stroke.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834890      PMCID: PMC27391          DOI: 10.1136/bmj.320.7248.1502

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

1.  Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators.

Authors:  J L Saver; K C Johnston; D Homer; R Wityk; W Koroshetz; L L Truskowski; E C Haley
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

2.  Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1985 Sep-Oct       Impact factor: 7.914

3.  Explaining stroke mortality trends.

Authors:  R Bonita; R Beaglehole
Journal:  Lancet       Date:  1993-06-12       Impact factor: 79.321

4.  Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study.

Authors:  C J Weir; G D Murray; A G Dyker; K R Lees
Journal:  BMJ       Date:  1997-05-03

5.  Early management and outcome of acute stroke in Auckland.

Authors:  N E Anderson; R Bonita; J B Broad
Journal:  Aust N Z J Med       Date:  1997-10

Review 6.  Neurally induced cardiac damage. Definition of the problem.

Authors:  M A Samuels
Journal:  Neurol Clin       Date:  1993-05       Impact factor: 3.806

7.  Cardiac sequelae of acute stroke.

Authors:  M G Myers; J W Norris; V C Hachinski; M E Weingert; M J Sole
Journal:  Stroke       Date:  1982 Nov-Dec       Impact factor: 7.914

8.  Serum cardiac enzymes in stroke.

Authors:  J W Norris; V C Hachinski; M G Myers; J Callow; T Wong; R W Moore
Journal:  Stroke       Date:  1979 Sep-Oct       Impact factor: 7.914

9.  Plasma norepinephrine in stroke.

Authors:  M G Myers; J W Norris; V C Hachniski; M J Sole
Journal:  Stroke       Date:  1981 Mar-Apr       Impact factor: 7.914

Review 10.  Cardioembolic stroke.

Authors:  M E Brickner
Journal:  Am J Med       Date:  1996-04       Impact factor: 4.965

View more
  43 in total

1.  Recognising "painless" heart attacks.

Authors:  C-K Wong; H D White
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice.

Authors:  P O Collinson; P J Stubbs; A-C Kessler
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

3.  Are troponins confusing?

Authors:  P O Collinson; P J Stubbs
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

4.  Concentrations of cardiac troponin T in neonates with and without respiratory distress.

Authors:  S J Clark; P Newland; C W Yoxall; N V Subhedar
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

5.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

Review 6.  Cardiac enzymes, renal failure and renal transplantation.

Authors:  Huseyin Bozbas; Aylin Yildirir; Haldun Muderrisoglu
Journal:  Clin Med Res       Date:  2006-03

7.  [Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society].

Authors:  U Laufs; U C Hoppe; S Rosenkranz; P Kirchhof; M Böhm; H-C Diener; M Endres; M Grond; W Hacke; T Meinertz; E B Ringelstein; J Röther; M Dichgans
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

8.  Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage.

Authors:  Kohei Hasegawa; Megan L Fix; Lauren Wendell; Kristin Schwab; Hakan Ay; Eric E Smith; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein; David F M Brown
Journal:  Am J Emerg Med       Date:  2011-03-29       Impact factor: 2.469

9.  Initial troponin level as a predictor of prognosis in patients with intracerebral hemorrhage.

Authors:  Pil-Wook Chung; Yu Sam Won; Young Joon Kwon; Chun Sik Choi; Byung Moon Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-06-30

Review 10.  [Elevated troponin and ECG alterations in acute ischemic stroke and subarachnoid hemorrhage].

Authors:  T Liman; M Endres
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.